Inducible Urticaria

• CLINICAL_TRIALS trial_result · 2026-06-08
  Clinical Trial Update: A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines [Phase 3]

  A Phase 3 clinical trial evaluating remibrutinib versus placebo for adults with chronic inducible urticaria inadequately controlled by H1-an…

• CLINICAL_TRIALS trial_result · 2026-03-27
  Clinical Trial Update: A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD) [Phase 3]

  Phase 3 study (EMBARQ - ColdU and SD) evaluating barzolvolimab versus placebo for cold-induced urticaria and symptomatic dermographism in ad…

• CLINICAL_TRIALS trial_result · 2025-11-06
  Clinical Trial Update: A Study of CDX-0159 in Patients With Chronic Inducible Urticaria [Phase 2]

  A Phase 2 study of CDX-0159 in chronic inducible urticaria has completed.

• CLINICAL_TRIALS trial_result · 2025-10-08
  Clinical Trial Update: A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines [Phase 1, Phase 2]

  This clinical trial update reports on a dose-escalation study of briquilimab in adults with chronic inducible urticaria that remained sympto…

• CLINICAL_TRIALS trial_result · 2025-06-18
  Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria [Phase 2]

  Phase 2 study evaluating EVO756 in adults with chronic inducible urticaria has completed, reporting on safety, tolerability, and efficacy.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-12-09
  Clinical Trial Update: Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria [Phase 1]

  Phase 1b open-label study evaluating the safety, tolerability, and pharmacodynamics of EP262 in subjects with chronic inducible urticaria ha…

• CLINICAL_TRIALS trial_result · 2024-11-22
  Clinical Trial Update: A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases [Phase 1]

  A single-dose, Phase 1 study of YH35324 in patients with allergic diseases, including chronic spontaneous urticaria and chronic inducible ur…

• CLINICAL_TRIALS trial_result · 2023-09-15
  Clinical Trial Update: Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines [Phase 3]

  A Phase 3 trial evaluating the efficacy and safety of ligelizumab in adolescents and adults with chronic inducible urticaria was terminated;…